Lanreotide [108736-35-2]

TargetMol Chemicals

Lanreotide [108736-35-2]

14

108736-35-2

Chemical

Research Use Only

Lanreotide

C54H69N11O10S2

1096.32

Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours.

3 years

CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@H](N)Cc1ccc2ccccc2c1

-20°C

12352200